Affordable OCT Lumedica is focused on affordable, high-tech diagnostic instruments and is actively bringing its first fully-patented OCT technology to market, presenting a clear opportunity to position cost-effective imaging solutions to hospitals and clinics seeking affordable diagnostic tools.

Academic Partnerships Recent and ongoing collaborations with major medical centers (University of Mississippi Medical Center and Duke University Medical Center) for clinical and commercial feasibility studies indicate strong interest from large institutions, suggesting channels for pilot deployments and co-developed proof points.

Grant-backed Growth Funding from NIH and the State of North Carolina, along with demonstrated fundraising capability, signals financial stability for early-stage sales cycles and potential for joint grant-funded deployment initiatives or subsidized procurement programs.

Mid-market Focus With a small team footprint and revenues in the low millions, Lumedica appears positioned to partner with mid-sized hospitals and specialty clinics seeking innovative, lower-cost imaging solutions without large enterprise-scale commitments.

Medical Imaging Demand The pursuit of OCT-based GI probes and other low-cost diagnostic technologies aligns with growing demand for point-of-care, high-accuracy imaging tools; targeted outreach to gastroenterology, ophthalmology, and radiology departments could generate multi-department adoption.